Showing results (281-290 of 383) with videos related to
Sort By:
Pageof 39
Bone Marrow Transplantation|June 16, 2009
TBI with lung dose reduction does not improve hematopoietic cell homing to BM during allogeneic transplantationA K Singh, J Chen, R Calado, et al.The Biochemical Journal|April 24, 1999
Pig kidney legumain: an asparaginyl endopeptidase with restricted specificityP M Dando, M Fortunato, L Smith, et al.Lancet (London, England)|December 23, 1978
Cyclosporin A for the treatment of graft-versus-host disease in manR L Powles, A J Barrett, H Clink, et al.British Journal of Haematology|March 1, 1996
Helper and cytotoxic lymphocyte responses to chronic myeloid leukaemia: implications for adoptive immunotherapy with T cellsP Lewalle, N Hensel, A Guimaraes, et al.British Journal of Haematology|January 1, 1991
Acute myeloid leukaemia relapsing following interleukin-2 treatment expresses the alpha chain of the interleukin-2 receptorD Macdonald, Y Z Jiang, D Swirsky, et al.British Journal of Haematology|September 30, 1998
Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor Vbeta profilesJ J Molldrem, Y Z Jiang, M Stetler-Stevenson, et al.Bone Marrow Transplantation|May 1, 1997
Preferential usage of T cell receptor (TCR) V beta by allogeneic T cells recognizing myeloid leukemia cells: implications for separating graft-versus-leukemia effect from graft-versus-host diseaseY Z Jiang, D A Mavroudis, S Dermime, et al.Clinical and Laboratory Haematology|January 1, 1984
Selective thrombocytopenia and neutropenia occurring after bone marrow transplantation--evidence of an auto-immune basisR M Minchinton, A H Waters, J S Malpas, et al.British Journal of Haematology|June 1, 1996
Alloreactive CD4+ T lymphocytes can exert cytotoxicity to chronic myeloid leukaemia cells processing and presenting exogenous antigenY Z Jiang, D Mavroudis, S Dermime, et al.British Journal of Haematology|February 26, 2000
CD34+ cell dose predicts relapse and survival after T-cell-depleted HLA-identical haematopoietic stem cell transplantation (HSCT) for haematological malignanciesE Bahçeci, E J Read, S Leitman, et al.Pageof 39